This page on Boron is currently marked as in-progress. We are still compiling research.
You can help contribute by:
Follow this Page for updates
The lowest active dose of Boron supplementation appears to be 3mg, which is effective in supporting hormonal parameters in postmenopausal women. Studies on osteoarthritis have used 6mg of Boron while studies in youth investigating hormonal changes have used 10mg.
The optimal dose is currently not known, but the above doses appear to be active for their aforementioned goals.
The Human Effect Matrix looks at human studies (excluding animal/petri-dish studies) to tell you what effect Boron has in your body, and how strong these effects are.
|Grade||Level of Evidence|
|A||Robust research conducted with repeated double blind clinical trials|
|B||Multiple studies where at least two are double-blind and placebo controlled|
|C||Single double blind study or multiple cohort studies|
|D||Uncontrolled or observational studies only|
|Level of Evidence ||Effect||Change||Magnitude of Effect Size ||Scientific Consensus||Comments|
Appears effective, but no comparison to a reference drug nor control group thus far
There appears to be an interaction with Boron and testosterone in both genders, but it is seemingly unreliable
Appears to influence estrogen, seems unreliable in its mechanisms and is likely context dependent. Both increases and decreases have been noted
Some influence on typically inflammatory cytokines, practical relevance of these changes unknown
No significant influences on serum DHT noted
Appears to be quite effective, but requires some more robust trials
No significant effect on cortisol has been noted with supplemental boron
No significant effect on this inflammatory biomarker
Boron is a dietary mineral that, although it has a daily intake, has not been accepted as an Essential Vitamin or Mineral. It currently does not have a known minimum requirement.
The most prominent sources of Boron in the diet are fruits, vegetables, tubers, and drinking water. It is also used in some industrial products, and the possibility of serum levels of boron being increased secondary to these is plausible, especially if coming into contact with wounds. Good sources of Boron are:
Products with a negligible (less than 0.015mcg/g) are:
Boron is a mineral which also participates as a Lewis acid, binding to hydroxyl groups (an anti-oxidant action, but likely to be insignificant due to low quantities of Boron de novo); when Boron binds to three hydroxyl groups, the structure is referred to as Boric Acid or Boracic Acid.
Boron appears to be absorbed from the intestines and is reported to be nearly complete as 84% of a radiolabelled dose has been found in the urine following an oral dose of 10mg in otherwise healthy persons.
It is thought that passive transportation may play a role as boron is the smallest known metalloid (this has been noted in plants) although plants have also shown transporters which accept boron selectively. In regards to mammals a sodium coupled borate transporter (NaBCl or SLC4A11) has been identified in rat, swine as well as human intestinal tissue and is responsive to dietary boron.
Boron appears to be well absorbed from the intestines, and this may be due to being absorbed (as borate) via the transporter known as SLC4A11
Oral administration of 11.4mg Boron (via 102.6mg sodium tetra borate decahydrate) alongside a meal can elevate plasma boron concentrations within one hour peaking at 4 hours post-consumption; fluctuating from 0.008-0.016mg/L in placebo yet spiking to 0.058mg/L at 1 hour and peaking at 0.136mg/L at 4 hours. This study failed to note differences in urinary boron concentrations for 2 days of collection. A study measuring effects of Boron in serum noted that standard boron supplementation at 10mg was able to influence select biomarkers according to the same timeline (with peak efficacy at 4 hours and some at 1 hour).
One study conducted in postmenopausal women given 3mg supplemental Boron found that the majority of supplemental born was excreted (primarily via the urine), which failed to support the notion that Boron builds up in the body. Extremely rapid boron excretion via the urine has been noted elsewhere in humans.
A Boron deficiency (intake of less than 0.23mg daily) appears to alter brainwave activity; enhancing delta power in the left parietal and temporal lobes and decreasing frontal lobe activity; similar results to intentional Magnesium deficiency. This state of deficiency is associated with cognitive impairment when paired against an adequate intake of 3mg or more which may be associated with Boron being involved in neuronal membrane stabilization.
May play a role in preserving neuronal function, but no intervention evidence exists to support supplementation currently
Oral administration of 11.6mg Boron fails to influence plasma insulin or glucose following a test meal despite serum levels of Boron being increased.
It has been hypothesized that 6mg daily Boron (tetraborate) could alleviate inflammation of the joints, which was followed by a pilot study in 20 patients with confirmed osteoarthritis showed 50% response (half of patients reporting benefit) with 55mg Sodium tetraborate decahydrate (6mg elemental Boron) suggesting some possible benefit to osteoarthritis. This may be related to the observation that the bone and synovial fluid of arthritic persons is less than healthy controls.
In a single-blind study assessing both athletic women and sedentary women given 3mg Boron (mixed chelation of Aspartate, Citrate, and Glycinate) daily for 10 months in conjunction with a Boron sufficient diet, Boron was associated with a slight reduction in circulating phosphorus levels (1.5mmol/L reduced to 1.3mmol/L in athletic; 1.7mmol/L reduced to 1.4mmol/L in sedentary) with no significant influence on calcium or Magnesium serum levels. There appeared to be a reduced urination of phosphorus and a slight increase in urinary calcium in female athletes only.
When Magnesium deficient, supplemental Boron still appears to suppress phosphorus urinary levels, the reduction of urinary calcium has been noted in women with low dietary Magnesium intake in another study and this was not noted alongside Magnesium supplementation (non-deficient).
6 days of supplementation of 10mg Boron is able to reduce TNF-a levels in serum by 19.1%, high sensitivity C-Reactive Protein by 45%, and IL-6 by 43.9% in otherwise healthy males.
Mechanistically, concentrations of boron in vitro in testicular homogenates are not associated with conversion rates of androstenedione to testosterone.
One study in otherwise healthy men noted that acute supplementation of Boron, over the period of 6 hours, failed to increase total testosterone levels yet trended to increase free testosterone (+14.7%) and DHT (+9.9%) although neither was statistically significant, yet significantly reduced Sex-Hormone Binding Globulin (SHBG) by 9% at the 6 hour mark yet required 2 hours to reach significance. After 7 days of supplementation, the increase in free testosterone (28.3%) reached significance yet the SHBG decrease was not. Another study using 4 weeks of 10mg Boron supplementation noted a trend towards increased testosterone (11.4%) but failed to reach statistical significance.
One study has been conducted on athletic males participating in bodybuilding, using a lower dose. 2.5mg of Boron daily for 9 weeks elevated plasma boron levels (20.1ppb to 32.6ppm; a 62% increase) yet failed to find significant differences between groups for any hormones measured.
In healthy male adults, supplemental Boron appears to be have mixed results. It has been implicated in increasing testosterone, but these may be dependent on time or dose as prolonged studies with the same or a lesser dose fail to replicate the increase in free testosterone seen in one study
In postmenopausal women on a Boron deficient diet (0.25mg daily), 3mg in supplementation can preserve a decrease in testosterone induced by the diet. The increase appeared to be of greater magnitude when dietary Magnesium was low, suggesting Boron may act on similar mechanisms.
Boron deficiency appears to reduce androgen status in women, and sufficiency can restore levels; a similar phenomena as seen with Zinc
One toxicological study in rats noted that, as it pertains to testosterone, that over 30 days of observation that there was an increase in testosterone in a dose-dependent manner up to 122% elevations (2000ppm) but that the progression of toxicological effects over 60 days reversed the increase in testosterone in the highest group to a decline while the lowest group (500mg) experiencing a 10.5% increase at day 30 increased this to 158% at day 60. These results suggest that boron accumulation in the testes contributes to an increase in testosterone, and time or dose can be contributing factors and have been replicated with 25mg/kg over 6 weeks (toxicity) while 2-12.5mg/kg were associated with improvements in testosterone.
In otherwise healthy adult men, 10mg of Boron daily for a week significantly reduces serum estradiol (an estrogen) from 42.33pg/mL to 25.81pg/mL (39%), although no significant effect was seen after a single dose when measured for 6 hours afterwards. Conversely, another study found 4 weeks of 10mg Boron found increases of serum estradiol from 51.9pmol/mL to 73.9pmol/L in 18 apparently healthy men.
Two studies on males and estrogen, with dichotomous results at the same dose in the same population
In postmenopausal women on a Boron deficienct diet, supplementation of Boron at 3mg/day is able to preserve estrogen levels that drop during boron deficiency.
In rats fed 500, 1000, or 2000ppm Boron for 60 days, a time and dose dependent increase in FSH was seen in all groups.
A week of 10mg Boron supplementation in otherwise healthy males fails to influence cortisol.
One rat study noted that higher doses (associated with testicular toxicity) had elevated testicular concentrations of boron, indicative of either selective accumulation of boron in the testicles or perhaps the concentration was skewed due to testicular atrophy; it was not noted with a lower dose of 500ppm.
In assessing a cohort of 35,222 men with 832 confirmed cases of prostate cancer over 3 years of surveillance, it was noted that the highest quartile was not significantly protected against prostate cancer when compared to the lowest quartile; respective RR was 1.17 (CI 0.85-1.61). This is in contrast to a previous study finding a RR of 0.63 indicating close to half the risk with a higher boron diet.
A letter to the editor of the Journal of Alternative and Complementary Medicine makes note of a small study with 14 participants. 10mg of Boron daily was given to persons with confirmed urolithiasis (kidney stones) and patients tended to report pain reduction after 2-3 days of treatment and multiple patients noted passing of kidney stones within a few weeks of treatmetn; the time to pass kidney stones was highly variable.
Preliminary evidence that Boron may aid kidney stone excretion and associated pain
Boron supplementation interacts with Vitamin D metabolism. This is exemplified by a boron-deficient diet (marginal in Magnesium and copper) reducing Vitamin D levels to 44.9nM 25-hyroxyvitamin D after 63 days but being increased back to 62.4nM after 49 days of repletion with 3mg Boron and an intervention using 6mg fructoborate (fruit storage form of boron) noting a 20% increase in 25-hydroxyvitamin D in Vitamin D deficient individuals, and was said to not be due to seasonal fluctuations.
Currently, these observations do not have proven mechanisms; one author hypothesized that boron may be reacting with a vitamin D metabolite to form a competitive inhibitor of 24-hydroxylase, an enzyme in Vitamin D synthesis, or otherwise directly inhibiting the enzyme. These hypothesis' has not been tested.
Appears to elevate levels of an intermediate between Vitamin D3 and hormonally active Vitamin D3, via unknown mechanisms
The Tolerable Upper Limit (TUL) of Boron has been set at 20mg daily for persons over the age of 18. This is slightly higher than the No Observable Adverse Upper Limit (NOAEL) of 17.5mg based on rat studies.
It has been noted that there is no clear evidence for testicular harm from excess boron exposure, which is in contrast to many dietary metals. Water levels of 6.5mg/L in a boron mining area are not associated with testicular harm and when serum levels were confirmed at 499.2ppb and concentrated in seminal fluid there was no adverse harm on seminal parameters nor have they been observed in a cohort averaging 14.45mg daily, with a range of intake exceeding 30mg.
These lack of toxic effects on the testicles have been extended to rats receiving 500ppm daily for 60 days, although 1000-2000ppm were associated with accumulation of testicular boron and testicular atrophy. These effects were replicated in rats exposed to 1173mg for 90 days.
Testicular harm from excess Boron levels appears to be at least three-fold higher than standard supplemental doses, and are likely not a concern with proper supplementation
It has been reported (no cited case studies) that oral doses of 5-6g Boron (5,000-6,000mg) in infants or 15-20g in adults (15,000-20,000mg) causes acute death in humans.
Boron, being used in pesticides, has some toxicological information in animals who are greatly overexposed to Boron.
(Common misspellings for Boron include borin, boring)
(Common phrases used by users for this page include what its boron citrate for, the mineral bornon and kidney stones, testosterone booster boron, boron testosterone boost, boron side effects, boron men)